Axel Licha, Radiotherapy Clinical Consultant at TheraPanacea, shared a post on LinkedIn:
“Every researcher remembers their first publication. Today is mine.
Seeing my first scientific paper published is something I’ll never forget. I’m proud to share our work, now published in Radiotherapy and Oncology (The Green Journal), investigating radiation-induced cardiac toxicity after SBRT for central and ultracentral lung tumors.
Key findings:
- 194 patients from three French cancer centers (162 evaluable) were included.
- Grade ≥2 cardiac toxicity occurred in 8.0% of patients, with a median onset of 12.6 months after SBRT.
- Two independent predictors of cardiac toxicity were identified: previous stroke (OR 4.17) and primary lung cancer (OR 4.03).
- Despite these findings, outcomes remained encouraging, with 78.3% local control, 83.4% overall survival at 2 years, and no cardiac-related deaths.
This publication is the result of an incredible collaborative effort. A huge thank you to Félix Felici, Leïla BOUAZZI, Coralie Barbe, Antoine Cordier, Loig DUVERGE, Amélie Lemoine, Elvire Mervoyer, Alexandra MOIGNIER, François Thillays, Loig Vaugier, and especially Dr. Arnaud Beddok MD PhD for his mentorship and for leading this project.
Finally, thank you to Institut Godinot for giving me the opportunity to grow as both a radiation oncologist and a clinical researcher.
My first publication… hopefully the first of many.”
Title: Radiation-induced cardiac toxicity after SBRT for central and ultracentral lung tumors: A multicenter retrospective cohort study
Authors: Axel Licha, Felix Felici, Leila Bouazzi, Coralie Barbe, Antoine Cordier, Loig Duverge, Amelie Lemoine, Elvire Martin-Mervoyer, Alexandra Moignier, François Thillays, Loig Vaugier, Arnaud Beddok
Read The Full Article
